Literature DB >> 3755052

Cimetidine absorption in humans during sucralfate coadministration.

R D'Angio, M Mayersohn, K A Conrad, M Bliss.   

Abstract

Cimetidine absorption after a single 300 mg oral dose was evaluated in six normal subjects in the absence or presence of sucralfate. Sucralfate was ingested four times a day for 2 days prior to and for two additional doses on the day of cimetidine ingestion. Sucralfate coadministration had no statistically significant influence on the rate or extent of cimetidine absorption.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3755052      PMCID： PMC1401033          DOI： 10.1111/j.1365-2125.1986.tb02834.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  21 in total

1.  Estimation of variance for harmonic mean half-lives.

Authors:  F C Lam; C T Hung; D G Perrier
Journal:  J Pharm Sci       Date:  1985-02       Impact factor: 3.534

2.  Bioavailability and pharmacokinetics of cimetidine.

Authors:  A Grahnén; C von Bahr; B Lindström; A Rosén
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

3.  Diminished absorption of cimetidine caused by antacids.

Authors:  G Bodemar; B Norlander; A Walan
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

4.  Effect of antacids on absorption of cimetidine.

Authors:  W L Burland; D W Darkin; M W Mills
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

5.  Selective binding of sucralfate to ulcer lesion. I. Experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate.

Authors:  R Nagashima; T Hirano
Journal:  Arzneimittelforschung       Date:  1980

6.  Bioavailability of cimetidine in man.

Authors:  S S Walkenstein; J W Dubb; W C Randolph; W J Westlake; R M Stote; A P Intoccia
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Inhibition of gastric acid secretion by cimetidine in patients with duodenal ulcer.

Authors:  R M Henn; J I Isenberg; V Maxwell; R A Sturdevant
Journal:  N Engl J Med       Date:  1975-08-21       Impact factor: 91.245

8.  Pharmacokinetics and bioavailability of cimetidine in humans.

Authors:  P V Pedersen; R Miller
Journal:  J Pharm Sci       Date:  1980-04       Impact factor: 3.534

9.  Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.

Authors:  N Yoshida; N Terao; R Nagashima
Journal:  Arzneimittelforschung       Date:  1980

10.  Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.

Authors:  L E Borella; K Seethaler; W Lippmann
Journal:  Arzneimittelforschung       Date:  1979
View more
  3 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Sucralfate reduces the gastrointestinal absorption of norfloxacin.

Authors:  S H Parpia; D E Nix; L G Hejmanowski; H R Goldstein; J H Wilton; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 3.  Clinical Drug-Drug Pharmacokinetic Interaction Potential of Sucralfate with Other Drugs: Review and Perspectives.

Authors:  Suresh P Sulochana; Muzeeb Syed; Devaraj V Chandrasekar; Ramesh Mullangi; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.